Characterisation of antibody responses induced by BCG and other TB vaccines to inform future vaccine design
Tuberculosis (TB) remains a pressing global health challenge. The focus of TB vaccine research traditionally centres on either enhancing BCG's efficacy or identifying a suit-able alternative. Within this context, antibody responses, a potentially relevant corre-late of protection, are inadequat...
1. autor: | Peralta Alvarez, MP |
---|---|
Kolejni autorzy: | Tanner, R |
Format: | Praca dyplomowa |
Język: | English |
Wydane: |
2023
|
Hasła przedmiotowe: |
Podobne zapisy
-
Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
od: Marco Polo Peralta Alvarez, i wsp.
Wydane: (2024-05-01) -
Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations
od: Shalini Pooransingh, i wsp.
Wydane: (2020-03-01) -
Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine
od: Nancy Gupta, i wsp.
Wydane: (2018-10-01) -
Commentary: Bettering BCG: a tough task for a TB vaccine?
od: Brahm S. Srivastava, i wsp.
Wydane: (2019-09-01) -
Mantoux test results and BCG vaccination status in TB-exposed children
od: Fadilah Harahap, i wsp.
Wydane: (2015-03-01)